Luke Sergott
Stock Analyst at Barclays
(2.16)
# 2,627
Out of 4,748 analysts
227
Total ratings
38.76%
Success rate
-4.12%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Initiates: Overweight | $200 | $168.22 | +18.89% | 1 | Jan 23, 2025 | |
| GH Guardant Health | Initiates: Overweight | $60 | $47.65 | +25.92% | 1 | Jan 23, 2025 | |
| EXAS Exact Sciences | Initiates: Overweight | $70 | $54.89 | +27.53% | 1 | Jan 23, 2025 | |
| A Agilent Technologies | Maintains: Underweight | $145 → $135 | $147.09 | -8.22% | 6 | Nov 27, 2024 | |
| RVTY Revvity | Maintains: Overweight | $140 → $135 | $123.52 | +9.29% | 7 | Nov 25, 2024 | |
| TWST Twist Bioscience | Maintains: Overweight | $55 → $52 | $49.52 | +5.01% | 16 | Nov 19, 2024 | |
| FTRE Fortrea Holdings | Maintains: Equal-Weight | $20 → $25 | $16.50 | +51.52% | 7 | Nov 11, 2024 | |
| CERT Certara | Maintains: Equal-Weight | $14 → $12 | $13.89 | -13.61% | 14 | Nov 7, 2024 | |
| ILMN Illumina | Maintains: Equal-Weight | $135 → $145 | $131.72 | +10.08% | 14 | Nov 5, 2024 | |
| WAT Waters | Maintains: Underweight | $330 → $360 | $404.17 | -10.93% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $260 → $255 | $198.07 | +28.74% | 19 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $21 → $19 | $14.84 | +28.03% | 8 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $25 | $21.49 | +16.33% | 20 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $330 → $275 | $198.12 | +38.80% | 16 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $620 → $610 | $568.23 | +7.35% | 23 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $285 → $275 | $223.73 | +22.92% | 36 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $230 → $210 | $161.64 | +29.92% | 2 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $17 | $13.68 | +24.27% | 16 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $3 → $2 | $1.56 | +28.21% | 4 | May 10, 2024 |
Natera
Jan 23, 2025
Initiates: Overweight
Price Target: $200
Current: $168.22
Upside: +18.89%
Guardant Health
Jan 23, 2025
Initiates: Overweight
Price Target: $60
Current: $47.65
Upside: +25.92%
Exact Sciences
Jan 23, 2025
Initiates: Overweight
Price Target: $70
Current: $54.89
Upside: +27.53%
Agilent Technologies
Nov 27, 2024
Maintains: Underweight
Price Target: $145 → $135
Current: $147.09
Upside: -8.22%
Revvity
Nov 25, 2024
Maintains: Overweight
Price Target: $140 → $135
Current: $123.52
Upside: +9.29%
Twist Bioscience
Nov 19, 2024
Maintains: Overweight
Price Target: $55 → $52
Current: $49.52
Upside: +5.01%
Fortrea Holdings
Nov 11, 2024
Maintains: Equal-Weight
Price Target: $20 → $25
Current: $16.50
Upside: +51.52%
Certara
Nov 7, 2024
Maintains: Equal-Weight
Price Target: $14 → $12
Current: $13.89
Upside: -13.61%
Illumina
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $135 → $145
Current: $131.72
Upside: +10.08%
Waters
Nov 4, 2024
Maintains: Underweight
Price Target: $330 → $360
Current: $404.17
Upside: -10.93%
Nov 1, 2024
Maintains: Overweight
Price Target: $260 → $255
Current: $198.07
Upside: +28.74%
Nov 1, 2024
Maintains: Overweight
Price Target: $21 → $19
Current: $14.84
Upside: +28.03%
Oct 25, 2024
Maintains: Overweight
Price Target: $28 → $25
Current: $21.49
Upside: +16.33%
Oct 25, 2024
Maintains: Overweight
Price Target: $330 → $275
Current: $198.12
Upside: +38.80%
Oct 23, 2024
Maintains: Equal-Weight
Price Target: $620 → $610
Current: $568.23
Upside: +7.35%
Oct 23, 2024
Maintains: Equal-Weight
Price Target: $285 → $275
Current: $223.73
Upside: +22.92%
Aug 8, 2024
Maintains: Equal-Weight
Price Target: $230 → $210
Current: $161.64
Upside: +29.92%
Aug 6, 2024
Maintains: Overweight
Price Target: $14 → $17
Current: $13.68
Upside: +24.27%
May 10, 2024
Maintains: Equal-Weight
Price Target: $3 → $2
Current: $1.56
Upside: +28.21%